First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid...

by Piha-Paul, Sarina A, Geva, Ravit, Tan, Tira J, Lim, Darren Wt, Hierro, Cinta, Doi, Toshikiko, Rahma, Osama, Lesokhin, Alexander, Luke, Jason John, Otero, Javier, Nardi, Lisa, Singh, Angad, Xyrafas, Alexandros, Chen, Xinhui, Mataraza, Jennifer, Bedard, Philippe L
Published 2022

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer

by Drogemoller, Britt I, Monzon, Jose G, Bhavsar, Amit P, Borrie, Adrienne E, Brooks, Beth, Wright, Galen EB, Liu, Geoffrey, Renouf, Daniel J, Kollmannsberger, Christian K, Bedard, Philippe L, Aminkeng, Folefac, Amstutz, Ursula, Hildebrand, Claudette A, Gunaretnam, Erandika P, Critchley, Carol, Chen, Zhuo, Brunham, Liam R, Hayden, Michael R, Ross, Colin JD, Gelmon, Karen A, Carleton, Bruce C
Published 2022